It is currently in Phase 3 clinical trials conducted by Eli Lilly
The only difference is FDA approval indication: Mounjaro is approved for type 2 diabetes, while Zepbound is approved for weight loss
In the first study, (ONeil.P et al, 2018) participants were subject to a 52 week randomised trial to investigate how efficient Semaglutide injections were for weight loss when compared with Liraglutide injections and a placebo
Read the guide What to Expect Your First Month on a GLP-1 Medication: A Week-by-Week Guide A week-by-week walkthrough of your first 30 days on semaglutide or tirzepatide from what to feel on day one to when to call your doctor, written by a physician who prescribes these medications daily
Mantener una silueta definida y una piel firme es un deseo comn, pero a menudo es difcil de lograr debido a factores como la gentica, el estilo de vida y el envejecimiento
Even those who question whether the medication is still working acknowledge they still feel full faster and think about food less often than before starting therapy